price
QG
NYSE · QGEN
Qiagen N.V.
Healthcare · Medical - Diagnostics & Research
$43.71
Up+$0.02 (+0.05%)
Updated Sep 24, 2026, 2:15 AM
SID Score
5.3/10
Composite research score
Smart Money
54/100
Neutral
- Market cap
- 9.85B
- P/E ratio
- 24.3
- Dividend yield
- 3.45%
- 52-week range
- $32.53 – $57.82
- Volume
- 3.03M
- Avg. volume
- 1.17M
Price performance
QGEN price history
1M range · 20 trading sessions · Daily adjusted prices
QGEN closed at $43.71 after 20 trading sessions, up 0.81% for the selected period.
- Last close
- $43.71
- Period change
- +0.81%
- Period low
- $41.88
- Period high
- $44.78
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 23, 2026 | $43.49 | $43.92 | $42.56 | $43.71 | 3.03M |
| Sep 22, 2026 | $44.43 | $44.47 | $43.615 | $43.69 | 1.45M |
| Sep 21, 2026 | $44.48 | $44.82 | $43.99 | $44.78 | 1.86M |
| Sep 18, 2026 | $44.30 | $44.36 | $43.31 | $43.33 | 1.75M |
| Sep 17, 2026 | $43.79 | $44.57 | $43.65 | $44.38 | 1.91M |
| Sep 16, 2026 | $42.58 | $43.455 | $42.56 | $42.90 | 1.37M |
| Sep 15, 2026 | $42.03 | $43.09 | $42.02 | $42.48 | 1.78M |
| Sep 14, 2026 | $42.92 | $42.94 | $41.74 | $41.88 | 2.04M |
| Sep 11, 2026 | $42.58 | $42.645 | $42.02 | $42.50 | 1.11M |
| Sep 10, 2026 | $42.00 | $42.625 | $41.89 | $42.13 | 1.25M |
| Sep 9, 2026 | $42.03 | $42.7299 | $41.91 | $42.50 | 1.1M |
| Sep 8, 2026 | $42.40 | $42.74 | $42.22 | $42.38 | 1.54M |
| Sep 4, 2026 | $43.19 | $43.66 | $42.79 | $43.47 | 1.92M |
| Sep 3, 2026 | $44.41 | $44.46 | $43.16 | $43.86 | 1.52M |
| Sep 2, 2026 | $43.63 | $44.915 | $43.63 | $44.20 | 2.2M |
| Sep 1, 2026 | $44.23 | $44.32 | $43.08 | $43.39 | 2.55M |
| Aug 31, 2026 | $43.04 | $43.48 | $42.57 | $43.29 | 1.35M |
| Aug 28, 2026 | $43.62 | $43.99 | $42.99 | $43.11 | 1.38M |
| Aug 27, 2026 | $43.63 | $44.18 | $43.63 | $43.74 | 1.58M |
| Aug 26, 2026 | $43.37 | $43.865 | $43.225 | $43.36 | 1.54M |
Latest QGEN news
The latest Smart Investors Daily articles mentioning QGEN.
Stock researchCompany · Earnings
Loading stock research…